Peptide Library

Human study PLS-00203

Biochemical characterization of thymic hormones in thymoma tissues.

Other design · 3 participants enrolled · not included in the assessments (other)

Version 1 · published November 8, 2026 · evidence through November 8, 2026 · research snapshot 2026.1.1 · methodology ev-1 · Automated assessment by AI (claude-opus-5-5 and claude-sonnet-5-5), not reviewed by a person.

Only the abstract was available. Essential methods may be missing, which limits what can be judged.

Reports of this study

Every publication, registration and abstract describing this one study. Participants are counted once.

  • Biochemical characterization of thymic hormones in thymoma tissues.primary · Thymus · 1990-03-01 · PMID 2333664

Design and participants

Design
Other design
Population
Three patients with thymic tumours (benign thymoma, invasive malignant thymoma, undifferentiated carcinoma) whose thymic tissue was biochemically analysed.
Conditions
Thymoma, Thymic carcinoma
Planned enrollment (registry)
Not reported
Enrolled
3
Randomized
Not reported
Completed follow-up
Not reported
Funding
The publication type indicates non-U.S. government research support. The funder is not named.

Intervention and comparator

What each group received. Related peptides, analogs and combinations are never treated as the compound itself.

    What the authors reported

    As stated in the sources. This is the authors’ account, not Peptide Library’s assessment.

    Adverse events

    None reported. That is not evidence of safety, and how safety was monitored isn’t described.

    The authors concluded (paraphrased): Thymic hormone content appeared to relate to thymoma type and differentiation. Benign thymoma contained both hormones, invasive malignant thymoma only Tβ4, and carcinoma neither. The authors suggest hormone content could aid pathological diagnosis.

    Peptide Library’s assessment

    An automated assessment, made by AI separately from the authors’ conclusions and not reviewed by a person. How risk of bias is assessed.

    Limitations

    • other: Endogenous Tβ4 was measured in tumour tissue. The compound was never administered, so the study gives no evidence on its effects or safety.
    • small or imprecise: Tissue came from only three thymoma patients, each with a different tumour type.
    • abstract only: Only the PubMed abstract is available, so methods and full results cannot be checked.
    • no control group: Three tissue samples were compared descriptively. There is no control group and no intervention.
    • inappropriate endpoint: Endogenous tissue peptide content is a biochemical measure. It is not a clinical outcome of administering the compound.

    No risk-of-bias assessment has been published for this study’s results.

    Claims this study informs

    Where each value comes from

    • author_conclusion: PMID 2333664, abstract (sentences 10-12) · extracted by AI (automated, not verified by a person) · abstract only
    • design: PMID 2333664, abstract (sentences 3-6) · extracted by AI (automated, not verified by a person) · abstract only
    • funding: PMID 2333664, title (publication types) · extracted by AI (automated, not verified by a person) · abstract only
    • participants: PMID 2333664, abstract (sentence 3) · extracted by AI (automated, not verified by a person) · abstract only
    • population: PMID 2333664, abstract (sentence 3) · extracted by AI (automated, not verified by a person) · abstract only

    • Version 1 · published November 8, 2026 · evidence through November 8, 2026 · research snapshot 2026.1.1 · methodology ev-1 · Automated assessment by AI (claude-opus-5-5 and claude-sonnet-5-5), not reviewed by a person.

    These assessments describe published research. Records marked automated were produced by AI under the published methodology and have not been reviewed by a person; they can contain errors. None of this is medical advice, not a statement about any product’s safety for human use, and not a regulatory approval. Peptide Library’s vendor and partner relationships play no part in them (editorial independence).